Susquehanna International Group’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,119
| Closed | -$41.2K | – | 5611 |
|
|
2024
Q2 | $41.2K | Buy |
+10,119
| New | +$41.2K | ﹤0.01% | 5304 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5531 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5915 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5535 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5629 |
|
|
2023
Q1 | – | Sell |
-668
| Closed | -$4.3K | – | 5961 |
|
|
2022
Q4 | $4.3K | Sell |
668
-215
| -24% | -$1.39K | ﹤0.01% | 5572 |
|
|
2022
Q3 | $11K | Sell |
883
-2,215
| -71% | -$27.6K | ﹤0.01% | 5808 |
|
|
2022
Q2 | $46K | Sell |
3,098
-2,470
| -44% | -$36.7K | ﹤0.01% | 5251 |
|
|
2022
Q1 | $208K | Buy |
5,568
+2,279
| +69% | +$85.1K | ﹤0.01% | 4777 |
|
|
2021
Q4 | $189K | Sell |
3,289
-6,694
| -67% | -$385K | ﹤0.01% | 4982 |
|
|
2021
Q3 | $1.02M | Buy |
9,983
+6,330
| +173% | +$647K | ﹤0.01% | 2735 |
|
|
2021
Q2 | $357K | Buy |
+3,653
| New | +$357K | ﹤0.01% | 4283 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5157 |
|